Back to Results
First PageMeta Content
Cash flow / Financial statements / Cash flow statement / Microbicides for sexually transmitted diseases / Condom / Operating cash flow / Working capital / Net asset value / Equity / Finance / Accountancy / Business


Quarterly Cashflow Report Melbourne, Australia; 31 October 2014: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today released its Appendix 4C – Quarterly Cashflow report for the period ended 30 SeptemberThe
Add to Reading List

Document Date: 2014-10-30 23:06:48

Open Document

File Size: 119,31 KB

Share Result on Facebook

City

Melbourne / /

Company

Melbourne Australia / Ansell Limited / Lilly / Woolworths / AstraZeneca / Okamoto Industries / Starpharma Holdings Ltd / /

Country

Japan / Australia / /

Currency

USD / /

/

Event

FDA Phase / Business Partnership / /

IndustryTerm

retail outlets / bank / marketed product / dendrimer products / pharmaceutical and medical uses / /

MarketIndex

ASX 300 / /

MedicalCondition

important cancer / bacterial vaginosis / tumour / recurrent bacterial vaginosis / /

MedicalTreatment

dendrimer / dendrimers / /

Organization

FDA / /

Person

Adama / Jackie Fairley / Rebecca Wilson Mob / Gabriella Hold / Nigel Baade / /

/

Position

general public pricing pressures / Chief Executive Officer / CFO and Company Secretary / Secretary / market leader / leader in the development / leader / world leader in the development / /

Product

LifeStyles / VivaGel / Taxotere / VivaGel® / DEP™ / Japan / /

Technology

drug delivery / /

URL

www.starpharma.com / /

SocialTag